ID

17259

Descrição

Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents in Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00332488

Link

https://clinicaltrials.gov/show/NCT00332488

Palavras-chave

Versões (1)
  1. 02/09/2016 02/09/2016 -
Transferido a

2 de setembro de 2016

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Diabetes Mellitus, Type 2 NCT00332488

Inglês

Eligibility Diabetes Mellitus, Type 2 NCT00332488

1 Formulários  
Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
non-smokers with clinical diagnosis of type 2 diabetes mellitus for >or= to 6 months
Descrição

Non-smoker | Diabetes Mellitus, Non-Insulin-Dependent

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0337672
UMLS CUI [2]
C0011860
stable regimen of metformin for > or = to 1000mg/day or maximum tolerated dose) and a secretagogue < or = 1/2 the maximum manufacturer-recommended daily dose without any dose adjustments within the preceding 6 wks.
Descrição

Metformin Stable status Quantity per day | Metformin Stable status Maximum Tolerated Dose | Pills Insulin Releasing

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0025598
UMLS CUI [1,2]
C0205360
UMLS CUI [1,3]
C1265611
UMLS CUI [1,4]
C0439505
UMLS CUI [2,1]
C0025598
UMLS CUI [2,2]
C0205360
UMLS CUI [2,3]
C0752079
UMLS CUI [3,1]
C0994475
UMLS CUI [3,2]
C0021641
UMLS CUI [3,3]
C1283071
fixed dose combination products of metformin and sulfonylurea are acceptable as long as each individual dose meets inclusion criteria
Descrição

Metformin | Sulfonylurea | Combination Product Acceptable

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0025598
UMLS CUI [2]
C0038766
UMLS CUI [3,1]
C1880146
UMLS CUI [3,2]
C1879533
hba1c >or= to 7.5% and < or= to 11.0%
Descrição

Glycosylated hemoglobin A

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0019018
bmi < or = to 40kg/m2.
Descrição

Body mass index

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1305855
fev1> or = to 70%, total lung capacity and > or =80% dlco > or= to 70%
Descrição

FEV1 | Total Lung Capacity | DLCO

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0748133
UMLS CUI [2]
C0040509
UMLS CUI [3]
C1516251
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
treatment with any type of anti-diabetic therapy, other than metformin &
Descrição

Antidiabetics | Metformin

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0935929
UMLS CUI [2]
C0025598
secretagogues within the preceding 12 weeks
Descrição

Pills Insulin Releasing

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0994475
UMLS CUI [1,2]
C0021641
UMLS CUI [1,3]
C1283071
serum creatinine > 1.4mg/dl in female subjects and >1.5mg/dl in male subjects
Descrição

Creatinine measurement, serum | Gender

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0201976
UMLS CUI [2]
C0079399
history of chronic obstructive pulmonary disease, clinically proven asthma and/or any other clinically important pulmonary function testing and/or radiologic findings
Descrição

Chronic Obstructive Airway Disease | Asthma | Pulmonary function tests Clinical Significance | Radiologic finding Clinical Significance

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0024117
UMLS CUI [2]
C0004096
UMLS CUI [3,1]
C0024119
UMLS CUI [3,2]
C2826293
UMLS CUI [4,1]
C1290916
UMLS CUI [4,2]
C2826293
evidence of serious complications of diabetes (e.g. autonomic neuropathy)
Descrição

Complications of Diabetes Mellitus Serious Evidence of | Autonomic neuropathy

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0342257
UMLS CUI [1,2]
C0205404
UMLS CUI [1,3]
C0332120
UMLS CUI [2]
C0259749
Voltar ao início da página

Similar models

Eligibility Diabetes Mellitus, Type 2 NCT00332488

1 Formulários
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
Non-smoker | Diabetes Mellitus, Non-Insulin-Dependent
Item
non-smokers with clinical diagnosis of type 2 diabetes mellitus for >or= to 6 months
boolean
C0337672 (UMLS CUI [1])
C0011860 (UMLS CUI [2])
Metformin Stable status Quantity per day | Metformin Stable status Maximum Tolerated Dose | Pills Insulin Releasing
Item
stable regimen of metformin for > or = to 1000mg/day or maximum tolerated dose) and a secretagogue < or = 1/2 the maximum manufacturer-recommended daily dose without any dose adjustments within the preceding 6 wks.
boolean
C0025598 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0439505 (UMLS CUI [1,4])
C0025598 (UMLS CUI [2,1])
C0205360 (UMLS CUI [2,2])
C0752079 (UMLS CUI [2,3])
C0994475 (UMLS CUI [3,1])
C0021641 (UMLS CUI [3,2])
C1283071 (UMLS CUI [3,3])
Metformin | Sulfonylurea | Combination Product Acceptable
Item
fixed dose combination products of metformin and sulfonylurea are acceptable as long as each individual dose meets inclusion criteria
boolean
C0025598 (UMLS CUI [1])
C0038766 (UMLS CUI [2])
C1880146 (UMLS CUI [3,1])
C1879533 (UMLS CUI [3,2])
Glycosylated hemoglobin A
Item
hba1c >or= to 7.5% and < or= to 11.0%
boolean
C0019018 (UMLS CUI [1])
Body mass index
Item
bmi < or = to 40kg/m2.
boolean
C1305855 (UMLS CUI [1])
FEV1 | Total Lung Capacity | DLCO
Item
fev1> or = to 70%, total lung capacity and > or =80% dlco > or= to 70%
boolean
C0748133 (UMLS CUI [1])
C0040509 (UMLS CUI [2])
C1516251 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
Antidiabetics | Metformin
Item
treatment with any type of anti-diabetic therapy, other than metformin &
boolean
C0935929 (UMLS CUI [1])
C0025598 (UMLS CUI [2])
Pills Insulin Releasing
Item
secretagogues within the preceding 12 weeks
boolean
C0994475 (UMLS CUI [1,1])
C0021641 (UMLS CUI [1,2])
C1283071 (UMLS CUI [1,3])
Creatinine measurement, serum | Gender
Item
serum creatinine > 1.4mg/dl in female subjects and >1.5mg/dl in male subjects
boolean
C0201976 (UMLS CUI [1])
C0079399 (UMLS CUI [2])
Chronic Obstructive Airway Disease | Asthma | Pulmonary function tests Clinical Significance | Radiologic finding Clinical Significance
Item
history of chronic obstructive pulmonary disease, clinically proven asthma and/or any other clinically important pulmonary function testing and/or radiologic findings
boolean
C0024117 (UMLS CUI [1])
C0004096 (UMLS CUI [2])
C0024119 (UMLS CUI [3,1])
C2826293 (UMLS CUI [3,2])
C1290916 (UMLS CUI [4,1])
C2826293 (UMLS CUI [4,2])
Complications of Diabetes Mellitus Serious Evidence of | Autonomic neuropathy
Item
evidence of serious complications of diabetes (e.g. autonomic neuropathy)
boolean
C0342257 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0332120 (UMLS CUI [1,3])
C0259749 (UMLS CUI [2])
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial